Childhood Acute Lymphocytic Leukemia

Open Access
Publisher Website
Google Scholar
Abstract
At present, significant numbers of children with ALL enjoy prolonged survival without serious sequelae. All children should be given the benefit of treatment under the supervision of physicians experienced in childhood cancer. Risk factors should be properly assessed and children at high risk placed in innovative programs. Longterm follow-up of patients is essential to detect, as early as possible, potentially prohibitive toxicity.

This publication has 0 references indexed in Scilit: